Target intelligence / Profile preview

Lymphatic vessels and lymphatic sinuses

Molecular classification
Other
01

Overview

The lymphatic vessels and lymphatic sinuses constitute a specialized vascular network responsible for maintaining tissue fluid balance, transporting dietary lipids, and facilitating the movement of immune cells to lymph nodes (StatPearls, 2023). Unlike the closed blood circulatory system, the lymphatic system is a one-way drainage network that begins in the interstitial spaces as blind-ended capillaries and converges into larger vessels and sinuses (NIH, 2024). In disease states, these structures play a critical role in the metastasis of solid tumors, as cancer cells often exploit lymphatic channels to spread to regional lymph nodes (Nature Reviews Cancer, 2006). Therapeutic strategies targeting this system often focus on modulating lymphangiogenesis—the growth of new lymphatic vessels—using inhibitors of the VEGF-C/VEGFR-3 signaling pathway to prevent metastasis or stimulators to treat lymphedema (Journal of Clinical Investigation, 2014). Additionally, the lymphatic sinuses within lymph nodes serve as vital hubs for antigen presentation and the initiation of adaptive immune responses, making them key sites for immunomodulatory interventions. The structural integrity and functional capacity of these vessels are also compromised in conditions like lymphatic filariasis and chronic inflammatory diseases, where lymphatic dysfunction exacerbates tissue swelling and immune evasion.

Other names
Lymphatic systemLymphatic vasculatureLymphatic capillariesLymphatic ductsLymphatic channels
02

Mechanism of action

Inhibition of lymphangiogenesis via VEGFR-3 signaling blockade; mTOR inhibition to reduce lymphatic malformation growth; PI3K inhibition; diagnostic visualization of lymphatic flow.

03

Biological functions

Immune responseOther
04

Disease associations

CancerInflammationInfectionOther
05

Safety considerations

Secondary lymphedemaImpaired immune cell traffickingDelayed wound healingFluid retention
06

Interacting drugs

Lenvatinib

6 more in the full profile.

07

Biomarkers

Podoplanin (D2-40)Lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1)Vascular endothelial growth factor receptor 3 (VEGFR-3)Prospero homeobox protein 1 (PROX1)

Beyond the preview

Go deeper on Lymphatic vessels and lymphatic sinuses.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphatic vessels and lymphatic sinuses.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call